课题基金 / 基金详情

Patient-oriented Research in Pediatric Diarrheal Diseases

Patient-oriented Research in Pediatric Diarrheal Diseases
以患者为中心的小儿腹泻病研究
批准号:
8294784
负责人:
CHRISTOPHER P DUGGAN
金额:
$19.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-19 至 2015-05-31

项目摘要

项目成果

CHRISTOPHER P DUGGAN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):胃肠道疾病在儿童中造成严重的发病率和死亡率。在发展中国家,感染性腹泻,包括与艾滋病毒/艾滋病有关的腹泻,是死亡的主要原因。在工业化国家,患有短肠综合征的儿童患有慢性腹泻,需要肠外和肠内营养治疗。这项修订后的申请要求克里斯托弗·杜根,医学博士,公共卫生硕士获得以患者为中心的研究(K24)职业中期研究员奖。杜根博士的总体研究目标是改善腹泻疾病的临床结果。他在营养、胃肠病学和国际卫生领域的资助研究中拥有高生产率的记录。达根博士在指导方面有良好的记录,也有与初级调查人员合作的绝佳机会。他是波士顿儿童医院(CHB)胃肠病和营养科临床研究主任,CHB临床研究计划教员,NIH支持的哈佛消化疾病研究中心成员,哈佛医学院儿科副教授和哈佛公共卫生学院营养学副教授。由两个T32培训计划支持的学员可作为学员。这项K24奖项中提议的研究扩展了Duggan博士正在进行的研究,包括由NICHD支持的R01赠款,旨在评估微量营养素补充剂对有腹泻风险的坦桑尼亚儿童的疗效。他和他的同事将进行一项随机临床试验:1.确定补充锌或微量营养素在预防坦桑尼亚儿童胃肠道感染方面是否具有特定种类的肠道病原体作用;2.确定与不含锌的微量营养素补充剂相比,常规补锌是否会降低坦桑尼亚儿童的铁状况指标。这个应用程序提供了一个在支持性和智力丰富的环境中非常成功的研究人员的组合。这个职业生涯中期的研究员奖是为了保护杜根博士的时间,以指导以患者为导向的营养研究的初学者,并扩大他在腹泻疾病方面的研究。) 与公共卫生的相关性:腹泻病是导致儿童死亡和发病的一个重要的世界性原因。这份K24职业发展奖的申请将评估补锌是否在降低坦桑尼亚儿童腹泻发病率方面具有特定物种的效果,并将支持申请者的指导能力,以促进年轻研究人员在营养、腹泻和全球卫生领域的职业生涯。
英文摘要
DESCRIPTION (provided by applicant): Diseases of the gastrointestinal tract cause significant morbidity and mortality among children. In developing countries, episodes of infectious diarrhea, including those associated with HIV/AIDS, are major causes of death. In industrialized countries, children with short bowel syndrome suffer from chronic diarrhea requiring treatment with parenteral and enteral nutrition. This revised application requests a mid-career investigator award in patient-oriented research (K24) for Christopher Duggan, MD, MPH. Dr. Duggan's overall research goal is to improve clinical outcomes in diarrheal diseases. He has a record of high productivity in funded research in the fields of nutrition, gastroenterology, and international health. Dr. Duggan has a sound track record of mentoring and excellent opportunities to work with junior investigators. He is Director of Clinical Research in the Division of Gastroenterology and Nutrition at Children's Hospital, Boston (CHB), a faculty member of the CHB Clinical Research Program, a member of the NIH-supported Harvard Digestive Diseases Research Center, and Associate Professor of Pediatrics at Harvard Medical School and of Nutrition at the Harvard School of Public Health. Trainees who are supported by two T32 training programs are available as mentees. The proposed research in this K24 award extends Dr. Duggan's ongoing studies, including an NICHD-supported R01 grant that seeks to evaluate the efficacy of micronutrient supplementation in Tanzanian children at risk of diarrhea. He and colleagues will conduct a randomized clinical trial: 1. To determine whether zinc or micronutrient supplementation has an enteropathogen species-specific effect in preventing gastrointestinal infections in Tanzanian children; and 2. To determine whether routine zinc supplementation reduces measures of iron status in Tanzanian children, compared to micronutrient supplements without zinc. This application offers a combination of a highly successful researcher in a supportive and intellectually rich environment. This mid-career investigator award is needed to protect Dr. Duggan's time to mentor beginning investigators in patient-oriented nutrition research and to expand his research in diarrheal diseases.) PUBLIC HEALTH RELEVANCE: Diarrheal diseases are an important world-wide cause of childhood mortality and morbidity. This application for a K24 career development award will evaluate whether zinc supplementation has a species-specific effect in reducing the incidence of diarrhea in Tanzanian children, and will support the mentoring capacity of the applicant to foster the career of young investigators in the areas of nutrition, diarrhea, and global health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Trial of Zinc Supplements for Young Infants with Clinical Severe Infection in Tanzania
  • 批准号:
    10635077
  • 项目类别:
  • 资助金额:
    $64.85万
  • 财政年份:
    2023
  • 负责人:
    CHRISTOPHER P DUGGAN
  • 依托单位:
Assessing the relationship between environmental enteric dysfunction and poor growth via a newly developed 11-plex assay
  • 批准号:
    10021657
  • 项目类别:
  • 资助金额:
    $18.52万
  • 财政年份:
    2019
  • 负责人:
    CHRISTOPHER P DUGGAN
  • 依托单位:
Patient-oriented Research in Pediatric Diarrheal Diseases
  • 批准号:
    8680269
  • 项目类别:
  • 资助金额:
    $19.11万
  • 财政年份:
    2010
  • 负责人:
    CHRISTOPHER P DUGGAN
  • 依托单位:
Patient-oriented Research in Pediatric Diarrheal Diseases
  • 批准号:
    8471737
  • 项目类别:
  • 资助金额:
    $19.11万
  • 财政年份:
    2010
  • 负责人:
    CHRISTOPHER P DUGGAN
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: